Delivery Order SPE2DB22D1106-SPE2DB25FDTM5

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $5,004.57 for the supply of Dupixent 300 mg/2 ml syringes. The contract has an ultimate completion date of July 11, 2024 and is a Firm Fixed Price agreement. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,709.46, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical program, worth up to $999,999,999 and running through November 2026. The contract provides for the delivery of Dupixent 300 mg/2 ml syringes to support military healthcare programs....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.46 firm-fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml syringes, with a period of performance through January 2, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,542.43, is a delivery order for the supply of Dupixent 300 mg/2 ml syringe, a specialty medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,709.46, is for the delivery of Dupixent 200 mg/1.14 ml syringes to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 6, 2025. The contract is not designated with a set-aside. In addition to this specific contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,652.35 Firm Fixed Price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, with a performance period through October 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,025.24, is for the delivery of Dupixent 300 mg/2 ml syringes. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,858.38, is for the delivery of Dupixent 200 mg/1.14 ml syringes. This is a firm fixed-price delivery order contract with a completion date of January 23, 2025. The contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,709.46 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, with an ultimate completion date of November 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,957.08 firm fixed-price delivery order is for Dupixent 300 mg/2 ml syringes, with an ultimate completion date of April 19, 2022. Amerisourcebergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the company to provide a comprehensive...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FDTM5
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,709.46, is for the delivery of Dupixent 300 mg/2 ml syringes to support military healthcare programs. This is a firm fixed-price delivery order contract with a performance period ending on January 8, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally.

Generated 4/8/25, 9:44 AM